Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet / Soverini, S; Hochhaus, A; Nicolini, Fe; Gruber, F; Lange, T; Saglio, G; Pane, Fabrizio; Müller, Mc; Ernst, T; Rosti, G; Porkka, K; Baccarani, M; Cross, Nc; Martinelli, G.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 118:5(2011), pp. 1-10.
Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.
PANE, FABRIZIO;
2011
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
